Rite Aid promotes two pharmacy executives
CAMP HILL, Pa. Rite Aid announced Monday the promotion of two executives.
Dan Miller, former VP pharmacy operations, has been promoted to SVP pharmacy; while Karen Staniforth, formerly regional pharmacy VP, has been promoted to VP pharmacy operations.
Miller, 53, a pharmacist and 30-year veteran of retail pharmacy, will be responsible for day-to-day pharmacy store operations with a focus on execution and customer service, clinical pharmacy programs, pharmacy acquisitions and pharmacy technology initiatives. Miller reports to Robert I. Thompson, Rite Aid EVP pharmacy.
“With 30 years experience in retail pharmacy, Dan brings an unmatched level of expertise to our company,” Thompson said. “Since joining Rite Aid two years ago, he’s made many significant contributions to our company. His experience and understanding of the chain drug industry will be instrumental in our continuing efforts to grow our business and improve the pharmacy customer experience.”
Staniforth, 48, a pharmacist with more than 20 years experience in retail pharmacy, will oversee and support field pharmacy operations as well as pharmacy standards of practice, regulatory compliance, policies and procedures. She reports to Miller.
“Karen’s extensive background and knowledge of retail pharmacy makes her an invaluable asset to our company,” Thompson said. “We’re fortunate to have her on the team, and we look forward to continuing to benefit from her talent and expertise as she takes on her new corporate responsibilities.”
Hy-Vee celebrates the other white meat
WEST DES MOINES, Iowa A lot of people complain about pork barrel spending, but not Midwest supermarket chain Hy-Vee.
October is National Pork Month, and the West Des Moines, Iowa-based Hy-Vee announced Friday that sales of the meat have increased more than 25% over October 2008. The chain said it was on track to increase pork tonnage by more than 30%.
“With pork prices the lowest they’ve been in more than a decade, we’ve focused our marketing efforts on promoting pork as a great value for consumers,” Hy-Vee assistant VP meat operations Kenan Judge said in a statement. “Today’s shopper is looking for nutritious, economical meal ideas, and pork perfectly fits the bill.”
Patients prefer new diabetes drug Victoza over its competitor, survey finds
MONTREAL A new diabetes drug satisfied patients more than its competitor, according to a study funded by the drug’s manufacturer.
According to data on 379 patients who took the Diabetes Treatment Satisfaction Questionnaires, presented Thursday at the 20th World Diabetes Congress and published in medical journal The Lancet, patients taking Novo Nordisk’s drug Victoza (liraglutide) perceived less abnormally low or high blood sugar levels — known respectively as hypoglycemia and hyperglycemia — than those taking Byetta (exenatide), made by Eli Lilly & Co., Amylin Corp. and Alkermes.
Victoza is approved in Europe, but Novo Nordisk is still waiting for approval from the Food and Drug Administration in the United States.
“Liraglutide has shown here in a convincing study that it is associated with less nausea, less perceived hypoglycemia and definitely higher patient satisfaction compared to exenatide,” principal investigator Wolfgang Schmidt said in a statement. “Patient-reported outcomes data is an important extension of the efficacy data. If a patient is satisfied with his or her treatment, then they are much more likely to really stick to the treatment over the long term, which is necessary in Type 2 diabetes.”